Celiac Disease — The Villain Unmasked?
Authors:
- Ross McManusRMRoss McManus
- Dermot KelleherDKDermot Kelleher
- 19 June 2003
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 348 (25) , 2573-2574
Abstract
The mechanism by which some types of cereal proteins trigger celiac disease (also known as gluten-sensitive enteropathy) is unknown. A strong candidate has now been put forward: a 33-amino-acid peptide that resists digestion. The peptide is susceptible to degradation by a bacterial enzyme, raising the possibility of a new therapeutic approach.Keywords
This publication has 5 references indexed in Scilit:
- Prevalence of Celiac Disease among Children in FinlandNew England Journal of Medicine, 2003
- Structural Basis for Gluten Intolerance in Celiac SprueScience, 2002
- Coeliac disease: dissecting a complex inflammatory disorderNature Reviews Immunology, 2002
- Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac diseaseNature Medicine, 1998
- Identification of tissue transglutaminase as the autoantigen of celiac diseaseNature Medicine, 1997